BackHeat Biologics Overview

Heat Biologics Other Current Liabilities

Latest other current liabilities for HTBX: $2.9T.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$2881.21B

Peer trimmed avg / median

Loading

Heat Biologics Other Current Liabilities History

Loading

Heat Biologics vs. peers: Other Current Liabilities Comparison

Loading

Heat Biologics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Heat Biologics (HTBX) FAQ

Heat Biologics (HTBX) currently reports a other current liabilities of $2.9T as of September 2025. Use the charts on this page to explore Heat Biologics's other current liabilities history and peer comparisons.

Heat Biologics reported $2.9T in other current liabilities as of September 2025. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $2.9T, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Heat Biologics, and consider following HTBX for alerts when major investors trade the stock.

Heat Biologics is classified in the Healthcare sector. On other current liabilities, it currently shows $2.9T. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HTBX with unrelated industries.